Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2024-000251
Request Summary: The draft product monograph included in the initial filing of the Abbreviated New Drug Submission (ANDS) for Aripiprazole from Jamp Pharma Corporation accepted into review in April 2024 and subsequently, included in the list of Generic submissions under review dated 2024-05-23 and the labels for all pack sizes for all strengths of the final dosage forms described in the ANDS.
Disposition: Disclosed in part
Number of pages: 563